

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 7.10104490 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 7.10104490 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.10104490 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.10104490 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.10104490 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 7.10104490 |
| 7 | microglial cell activation (GO:0001774) | 6.90718713 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.86674210 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 6.25911460 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.81930289 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 5.41308722 |
| 12 | positive regulation of chemokine secretion (GO:0090197) | 5.12724777 |
| 13 | amino sugar catabolic process (GO:0046348) | 4.88730249 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.83951137 |
| 15 | macrophage activation (GO:0042116) | 4.65622936 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.60463123 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.53735464 |
| 18 | response to host immune response (GO:0052572) | 4.53735464 |
| 19 | keratan sulfate catabolic process (GO:0042340) | 4.52369931 |
| 20 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.49272119 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.39957500 |
| 22 | N-acetylneuraminate metabolic process (GO:0006054) | 4.32814214 |
| 23 | response to host (GO:0075136) | 4.26570550 |
| 24 | response to host defenses (GO:0052200) | 4.26570550 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.26570550 |
| 26 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.09589342 |
| 27 | virion attachment to host cell (GO:0019062) | 4.08202900 |
| 28 | T-helper 1 type immune response (GO:0042088) | 4.05592416 |
| 29 | membrane lipid catabolic process (GO:0046466) | 4.00758098 |
| 30 | glycosphingolipid catabolic process (GO:0046479) | 3.97351200 |
| 31 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.96800652 |
| 32 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.95546353 |
| 33 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.95113164 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.93792376 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91789366 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 3.88381178 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86999527 |
| 38 | sphingolipid catabolic process (GO:0030149) | 3.84374024 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.77715140 |
| 40 | regulation of chemokine secretion (GO:0090196) | 3.77695367 |
| 41 | hyaluronan catabolic process (GO:0030214) | 3.66918225 |
| 42 | regulation of podosome assembly (GO:0071801) | 3.63666147 |
| 43 | adhesion of symbiont to host (GO:0044406) | 3.61772058 |
| 44 | oligosaccharide catabolic process (GO:0009313) | 3.60530227 |
| 45 | mannose metabolic process (GO:0006013) | 3.57972095 |
| 46 | positive regulation of heat generation (GO:0031652) | 3.53747898 |
| 47 | I-kappaB phosphorylation (GO:0007252) | 3.53441960 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.50471799 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.50065366 |
| 50 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.49182117 |
| 51 | glycolipid catabolic process (GO:0019377) | 3.48897726 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.48461843 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.47632329 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.45016882 |
| 55 | monocyte chemotaxis (GO:0002548) | 3.44283582 |
| 56 | regulation of chemokine biosynthetic process (GO:0045073) | 3.42258929 |
| 57 | barbed-end actin filament capping (GO:0051016) | 3.41744534 |
| 58 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.41027273 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.39969925 |
| 60 | pinocytosis (GO:0006907) | 3.36559485 |
| 61 | respiratory burst (GO:0045730) | 3.34717758 |
| 62 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32287936 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 3.31555190 |
| 64 | regulation of fever generation (GO:0031620) | 3.30476519 |
| 65 | cellular response to arsenic-containing substance (GO:0071243) | 3.28552873 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28189297 |
| 67 | response to thyroid hormone (GO:0097066) | 3.28160428 |
| 68 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.27408769 |
| 69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25983594 |
| 70 | apoptotic cell clearance (GO:0043277) | 3.25802550 |
| 71 | response to peptidoglycan (GO:0032494) | 3.24519876 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19471258 |
| 73 | regulation of vitamin metabolic process (GO:0030656) | 3.17952655 |
| 74 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.16915252 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.16463962 |
| 76 | positive regulation of mast cell degranulation (GO:0043306) | 3.16463962 |
| 77 | positive regulation of interferon-beta production (GO:0032728) | 3.15638957 |
| 78 | regulation of macrophage chemotaxis (GO:0010758) | 3.14187766 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 3.12843722 |
| 80 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.12472165 |
| 81 | regulation of antigen processing and presentation (GO:0002577) | 3.09801163 |
| 82 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.07578583 |
| 83 | myeloid dendritic cell activation (GO:0001773) | 3.05373455 |
| 84 | ceramide catabolic process (GO:0046514) | 3.04444955 |
| 85 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.03459303 |
| 86 | negative regulation of interleukin-6 production (GO:0032715) | 3.02504976 |
| 87 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.94644404 |
| 88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93859498 |
| 89 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.91451693 |
| 90 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89142004 |
| 91 | regulation of chronic inflammatory response (GO:0002676) | 2.87357360 |
| 92 | cellular response to lipopolysaccharide (GO:0071222) | 2.86363205 |
| 93 | adenosine receptor signaling pathway (GO:0001973) | 2.85965708 |
| 94 | positive regulation of cholesterol efflux (GO:0010875) | 2.83655814 |
| 95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83552322 |
| 96 | regulation of cholesterol storage (GO:0010885) | 2.82730798 |
| 97 | negative regulation of mast cell activation (GO:0033004) | 2.80589597 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 2.79345994 |
| 99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77857517 |
| 100 | cellular response to molecule of bacterial origin (GO:0071219) | 2.75829186 |
| 101 | B cell mediated immunity (GO:0019724) | 2.75173190 |
| 102 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.74945485 |
| 103 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74577505 |
| 104 | purinergic receptor signaling pathway (GO:0035587) | 2.73949395 |
| 105 | plasma lipoprotein particle clearance (GO:0034381) | 2.71694128 |
| 106 | regulation of superoxide anion generation (GO:0032928) | 2.71550029 |
| 107 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.70119310 |
| 108 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.68738805 |
| 109 | myeloid leukocyte activation (GO:0002274) | 2.68586008 |
| 110 | positive regulation of interleukin-6 production (GO:0032755) | 2.67984083 |
| 111 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.67783747 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.67678204 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.67678204 |
| 114 | protein localization to endosome (GO:0036010) | 2.67502361 |
| 115 | toxin transport (GO:1901998) | 2.66753836 |
| 116 | regulation of heat generation (GO:0031650) | 2.66724682 |
| 117 | granulocyte activation (GO:0036230) | 2.66558499 |
| 118 | phagosome maturation (GO:0090382) | 2.66061043 |
| 119 | negative regulation of interleukin-17 production (GO:0032700) | 2.65738260 |
| 120 | response to lipoprotein particle (GO:0055094) | 2.65117872 |
| 121 | positive regulation of chemokine production (GO:0032722) | 2.65012721 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 2.63924262 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63718810 |
| 124 | ruffle organization (GO:0031529) | 2.63072970 |
| 125 | chondroitin sulfate catabolic process (GO:0030207) | 2.62804615 |
| 126 | regulation of mast cell degranulation (GO:0043304) | 2.62324672 |
| 127 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.62200159 |
| 128 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61291179 |
| 129 | detection of molecule of bacterial origin (GO:0032490) | 2.59357633 |
| 130 | phagocytosis, engulfment (GO:0006911) | 2.57859932 |
| 131 | cellular extravasation (GO:0045123) | 2.57230185 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.57067968 |
| 133 | positive regulation of macrophage cytokine production (GO:0060907) | 2.55743962 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.54981999 |
| 135 | neutrophil activation (GO:0042119) | 2.54942300 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.53133981 |
| 137 | cytidine deamination (GO:0009972) | 2.52241023 |
| 138 | cytidine metabolic process (GO:0046087) | 2.52241023 |
| 139 | cytidine catabolic process (GO:0006216) | 2.52241023 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.50580366 |
| 141 | lytic vacuole organization (GO:0080171) | 2.49274106 |
| 142 | lysosome organization (GO:0007040) | 2.49274106 |
| 143 | positive regulation of leukocyte degranulation (GO:0043302) | 2.47184024 |
| 144 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.42304046 |
| 145 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.41263546 |
| 146 | negative regulation of bone resorption (GO:0045779) | 2.39389084 |
| 147 | basic amino acid transport (GO:0015802) | 2.39291849 |
| 148 | regulation of leukocyte degranulation (GO:0043300) | 2.39203143 |
| 149 | regulation of monocyte chemotaxis (GO:0090025) | 2.37030487 |
| 150 | regulation of mast cell activation (GO:0033003) | 2.36915899 |
| 151 | negative regulation of B cell proliferation (GO:0030889) | 2.35859628 |
| 152 | cell adhesion mediated by integrin (GO:0033627) | 2.32362810 |
| 153 | positive regulation of mast cell activation (GO:0033005) | 2.32300763 |
| 154 | negative regulation of tissue remodeling (GO:0034104) | 2.31384062 |
| 155 | dendritic cell differentiation (GO:0097028) | 2.31119340 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.30083496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.89522424 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.06153878 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47805262 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.38051734 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.01271887 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.39251995 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26497458 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.26362197 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47888876 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46980322 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23508540 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19020929 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.14289558 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05539222 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00361022 |
| 16 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.99925382 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92160769 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87766061 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87432049 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87084453 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81144321 |
| 22 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.80676288 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77518233 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77113256 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74835919 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71058983 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67600721 |
| 28 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67206271 |
| 29 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61770171 |
| 30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.58966072 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57809321 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57479349 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52052227 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51310482 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49907558 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49876648 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49434030 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48414930 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48085551 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46517542 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45400069 |
| 42 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.43289111 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42599530 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37820519 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36548620 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32527030 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31851031 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30946203 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30806221 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29994081 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28263560 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26699199 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26447028 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26409815 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26237968 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23610007 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22205021 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21368593 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21229573 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19972583 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19618453 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19193048 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19185088 |
| 64 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18279612 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17924180 |
| 66 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16340980 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16160695 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15528963 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15222490 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14751521 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09395211 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.08648876 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08490584 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06672330 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06073660 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05311628 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04709878 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03663696 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03329779 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03041890 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02942913 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02645132 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02611198 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02045033 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01703169 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00854579 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00792124 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97727322 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97691724 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97183937 |
| 91 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96816984 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94905845 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94675407 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94229361 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94054949 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93916685 |
| 97 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93496331 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93132398 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93055040 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93008071 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92806861 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92256220 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91870013 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91511946 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90890835 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90890835 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90890348 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90719975 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90604900 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89642209 |
| 111 | MYB_26560356_Chip-Seq_TH2_Human | 0.89447611 |
| 112 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87769275 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87324580 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86408517 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86087956 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85816054 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85635533 |
| 118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85524402 |
| 119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83373525 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83136262 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81727560 |
| 122 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81687533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005058_abnormal_lysosome_morphology | 5.40700464 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.43167594 |
| 3 | MP0003172_abnormal_lysosome_physiology | 4.03474122 |
| 4 | MP0006082_CNS_inflammation | 3.99722261 |
| 5 | MP0009840_abnormal_foam_cell | 3.56408659 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.48871088 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.35701342 |
| 8 | MP0003303_peritoneal_inflammation | 2.90785736 |
| 9 | MP0003690_abnormal_glial_cell | 2.80638839 |
| 10 | MP0003436_decreased_susceptibility_to | 2.51093427 |
| 11 | * MP0002419_abnormal_innate_immunity | 2.49477590 |
| 12 | MP0003075_altered_response_to | 2.16989755 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.15844941 |
| 14 | MP0000604_amyloidosis | 2.13227447 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.13179035 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.10487461 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.10006682 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.03385814 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.02694731 |
| 20 | MP0000343_altered_response_to | 1.99006685 |
| 21 | MP0004510_myositis | 1.89313391 |
| 22 | MP0005671_abnormal_response_to | 1.88170251 |
| 23 | MP0003724_increased_susceptibility_to | 1.83245501 |
| 24 | * MP0002452_abnormal_antigen_presenting | 1.82274025 |
| 25 | MP0005451_abnormal_body_composition | 1.76258761 |
| 26 | MP0002998_abnormal_bone_remodeling | 1.73870969 |
| 27 | MP0006054_spinal_hemorrhage | 1.69080146 |
| 28 | MP0005387_immune_system_phenotype | 1.65920071 |
| 29 | MP0001790_abnormal_immune_system | 1.65920071 |
| 30 | MP0005025_abnormal_response_to | 1.64138125 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.62932304 |
| 32 | MP0005166_decreased_susceptibility_to | 1.60848828 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.58278906 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.57574889 |
| 35 | * MP0002723_abnormal_immune_serum | 1.54250190 |
| 36 | MP0001958_emphysema | 1.51366229 |
| 37 | MP0001800_abnormal_humoral_immune | 1.49605115 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.49350886 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.47108361 |
| 40 | MP0009785_altered_susceptibility_to | 1.45343802 |
| 41 | * MP0008469_abnormal_protein_level | 1.42521798 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.38673753 |
| 43 | MP0005310_abnormal_salivary_gland | 1.38602316 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.36998660 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.36847970 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.36847970 |
| 47 | * MP0001819_abnormal_immune_cell | 1.34922348 |
| 48 | * MP0002420_abnormal_adaptive_immunity | 1.31472027 |
| 49 | MP0002090_abnormal_vision | 1.29356937 |
| 50 | MP0003329_amyloid_beta_deposits | 1.28654175 |
| 51 | MP0002136_abnormal_kidney_physiology | 1.27955158 |
| 52 | MP0005365_abnormal_bile_salt | 1.26694190 |
| 53 | MP0003279_aneurysm | 1.25679684 |
| 54 | MP0005670_abnormal_white_adipose | 1.25336943 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.23464418 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.22032899 |
| 57 | MP0000685_abnormal_immune_system | 1.20989264 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.20432546 |
| 59 | MP0004883_abnormal_blood_vessel | 1.19117751 |
| 60 | MP0001542_abnormal_bone_strength | 1.18729743 |
| 61 | MP0001756_abnormal_urination | 1.17683301 |
| 62 | MP0000920_abnormal_myelination | 1.15493640 |
| 63 | MP0008004_abnormal_stomach_pH | 1.14951626 |
| 64 | MP0004858_abnormal_nervous_system | 1.13739079 |
| 65 | MP0002405_respiratory_system_inflammati | 1.12324155 |
| 66 | MP0001851_eye_inflammation | 1.12241131 |
| 67 | MP0003448_altered_tumor_morphology | 1.10180301 |
| 68 | MP0003195_calcinosis | 1.09670176 |
| 69 | MP0003634_abnormal_glial_cell | 1.09404374 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.09164555 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.05099442 |
| 72 | MP0005165_increased_susceptibility_to | 1.04634962 |
| 73 | MP0002933_joint_inflammation | 1.04359931 |
| 74 | MP0009278_abnormal_bone_marrow | 1.04031477 |
| 75 | MP0001915_intracranial_hemorrhage | 1.03913778 |
| 76 | MP0009764_decreased_sensitivity_to | 1.03836695 |
| 77 | MP0004947_skin_inflammation | 1.03636282 |
| 78 | MP0002254_reproductive_system_inflammat | 1.01801446 |
| 79 | MP0005164_abnormal_response_to | 0.99983887 |
| 80 | MP0000249_abnormal_blood_vessel | 0.99644892 |
| 81 | MP0003045_fibrosis | 0.97049297 |
| 82 | MP0005360_urolithiasis | 0.94587304 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.94414501 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 0.93021445 |
| 85 | MP0005390_skeleton_phenotype | 0.92667962 |
| 86 | MP0003252_abnormal_bile_duct | 0.92560016 |
| 87 | MP0005332_abnormal_amino_acid | 0.92407080 |
| 88 | MP0003186_abnormal_redox_activity | 0.91632285 |
| 89 | * MP0000689_abnormal_spleen_morphology | 0.91150337 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.88469062 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.86867741 |
| 92 | MP0001853_heart_inflammation | 0.86831303 |
| 93 | * MP0000716_abnormal_immune_system | 0.85777467 |
| 94 | MP0003795_abnormal_bone_structure | 0.84917004 |
| 95 | MP0008260_abnormal_autophagy | 0.84109739 |
| 96 | MP0009763_increased_sensitivity_to | 0.83695962 |
| 97 | MP0003091_abnormal_cell_migration | 0.82797649 |
| 98 | MP0005023_abnormal_wound_healing | 0.82555955 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80244846 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.79583053 |
| 101 | MP0001663_abnormal_digestive_system | 0.79382748 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.78992151 |
| 103 | MP0010307_abnormal_tumor_latency | 0.78960357 |
| 104 | MP0003633_abnormal_nervous_system | 0.78824384 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.76573566 |
| 106 | * MP0002135_abnormal_kidney_morphology | 0.75438822 |
| 107 | MP0005647_abnormal_sex_gland | 0.75089077 |
| 108 | MP0003828_pulmonary_edema | 0.73882707 |
| 109 | MP0004130_abnormal_muscle_cell | 0.72943014 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.72776609 |
| 111 | MP0000538_abnormal_urinary_bladder | 0.71479698 |
| 112 | MP0003879_abnormal_hair_cell | 0.69845242 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.69319637 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.68947395 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.68932513 |
| 116 | MP0000609_abnormal_liver_physiology | 0.68387936 |
| 117 | * MP0002429_abnormal_blood_cell | 0.68331957 |
| 118 | MP0000858_altered_metastatic_potential | 0.67818758 |
| 119 | MP0002928_abnormal_bile_duct | 0.67582972 |
| 120 | MP0000371_diluted_coat_color | 0.66847313 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.61085865 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.58016426 |
| 123 | MP0008874_decreased_physiological_sensi | 0.56571136 |
| 124 | MP0001849_ear_inflammation | 0.55260581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.48069465 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.40751930 |
| 3 | Glomerulonephritis (HP:0000099) | 6.37234168 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.24992132 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 6.24992132 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.24992132 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.87911096 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.59186272 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 5.51858807 |
| 10 | Complement deficiency (HP:0004431) | 4.86193949 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.57034114 |
| 12 | Axonal loss (HP:0003447) | 4.56911672 |
| 13 | Mucopolysacchariduria (HP:0008155) | 4.45647851 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.45647851 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.22268825 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.22268825 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.22268825 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.19806210 |
| 19 | Nuclear cataract (HP:0100018) | 4.19586871 |
| 20 | Abnormality of complement system (HP:0005339) | 3.91408609 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.86642739 |
| 22 | Disinhibition (HP:0000734) | 3.59699989 |
| 23 | Mutism (HP:0002300) | 3.58115258 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.56734489 |
| 25 | Nephritis (HP:0000123) | 3.55689231 |
| 26 | Retinal atrophy (HP:0001105) | 3.54470410 |
| 27 | Cerebral aneurysm (HP:0004944) | 3.40886874 |
| 28 | Arterial tortuosity (HP:0005116) | 3.39430607 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.38558040 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.21623752 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13284007 |
| 32 | Vascular tortuosity (HP:0004948) | 3.04024005 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 2.99052841 |
| 34 | Purpura (HP:0000979) | 2.97213281 |
| 35 | Loss of speech (HP:0002371) | 2.91351025 |
| 36 | Neuronal loss in central nervous system (HP:0002529) | 2.83966204 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.83381714 |
| 38 | Hematochezia (HP:0002573) | 2.81305318 |
| 39 | Pathologic fracture (HP:0002756) | 2.76095584 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.63508313 |
| 41 | Orchitis (HP:0100796) | 2.59340571 |
| 42 | Metaphyseal irregularity (HP:0003025) | 2.58568124 |
| 43 | Upper motor neuron abnormality (HP:0002127) | 2.58083022 |
| 44 | Prolonged neonatal jaundice (HP:0006579) | 2.54046590 |
| 45 | Agnosia (HP:0010524) | 2.53772440 |
| 46 | Progressive neurologic deterioration (HP:0002344) | 2.49008025 |
| 47 | Increased serum ferritin (HP:0003281) | 2.48899944 |
| 48 | Peripheral demyelination (HP:0011096) | 2.44092890 |
| 49 | Optic neuritis (HP:0100653) | 2.42768226 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.42768226 |
| 51 | Myocardial infarction (HP:0001658) | 2.41586309 |
| 52 | Ovoid vertebral bodies (HP:0003300) | 2.38237657 |
| 53 | Aortic aneurysm (HP:0004942) | 2.37198643 |
| 54 | Spondylolisthesis (HP:0003302) | 2.35185516 |
| 55 | Stomatitis (HP:0010280) | 2.33095438 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.32716422 |
| 57 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29550929 |
| 58 | Progressive visual loss (HP:0000529) | 2.27771375 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.26631237 |
| 60 | Recurrent skin infections (HP:0001581) | 2.24134409 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.22588401 |
| 62 | Thoracic kyphosis (HP:0002942) | 2.21704092 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.18345008 |
| 64 | Cardiomegaly (HP:0001640) | 2.17536885 |
| 65 | Abnormality of the lumbar spine (HP:0100712) | 2.16377312 |
| 66 | Striae distensae (HP:0001065) | 2.13320637 |
| 67 | Aortic dissection (HP:0002647) | 2.09914771 |
| 68 | Increased CSF protein (HP:0002922) | 2.09750296 |
| 69 | Apathy (HP:0000741) | 2.09412444 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.09244563 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09244563 |
| 72 | Colitis (HP:0002583) | 2.04641338 |
| 73 | Disproportionate tall stature (HP:0001519) | 2.04438740 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.02002643 |
| 75 | Joint stiffness (HP:0001387) | 2.01937299 |
| 76 | Gingivitis (HP:0000230) | 2.01915389 |
| 77 | Diminished motivation (HP:0000745) | 2.01720307 |
| 78 | Polyneuropathy (HP:0001271) | 2.00539155 |
| 79 | Bone pain (HP:0002653) | 2.00224714 |
| 80 | Nausea (HP:0002018) | 1.99258060 |
| 81 | Multiple enchondromatosis (HP:0005701) | 1.98749118 |
| 82 | Beaking of vertebral bodies (HP:0004568) | 1.98129217 |
| 83 | Thick nail (HP:0001805) | 1.97931661 |
| 84 | Pulmonary infiltrates (HP:0002113) | 1.96824774 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95717669 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 1.95435132 |
| 87 | Global brain atrophy (HP:0002283) | 1.95055877 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 1.94350314 |
| 89 | Myositis (HP:0100614) | 1.92443129 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.92020624 |
| 91 | Amyloidosis (HP:0011034) | 1.91798745 |
| 92 | Abnormality of the periventricular white matter (HP:0002518) | 1.91354479 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 1.90719254 |
| 94 | Dementia (HP:0000726) | 1.87482662 |
| 95 | Malnutrition (HP:0004395) | 1.84291406 |
| 96 | Memory impairment (HP:0002354) | 1.82915960 |
| 97 | Cervical subluxation (HP:0003308) | 1.82499221 |
| 98 | Xanthomatosis (HP:0000991) | 1.81995783 |
| 99 | Zonular cataract (HP:0010920) | 1.81734782 |
| 100 | Abnormal platelet function (HP:0011869) | 1.79929785 |
| 101 | Impaired platelet aggregation (HP:0003540) | 1.79929785 |
| 102 | Metabolic alkalosis (HP:0200114) | 1.79658445 |
| 103 | Urethral obstruction (HP:0000796) | 1.78901584 |
| 104 | Mesangial abnormality (HP:0001966) | 1.77885818 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 1.76339196 |
| 106 | Hypokalemic alkalosis (HP:0001949) | 1.76261568 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.74026309 |
| 108 | Hydroxyprolinuria (HP:0003080) | 1.74026309 |
| 109 | Vertebral compression fractures (HP:0002953) | 1.73616344 |
| 110 | Personality changes (HP:0000751) | 1.72670771 |
| 111 | Spontaneous hematomas (HP:0007420) | 1.71626771 |
| 112 | Obstructive lung disease (HP:0006536) | 1.70042327 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70042327 |
| 114 | Poor head control (HP:0002421) | 1.69786724 |
| 115 | Abnormality of the basal ganglia (HP:0002134) | 1.69605986 |
| 116 | Acrocyanosis (HP:0001063) | 1.69087671 |
| 117 | Clumsiness (HP:0002312) | 1.68296214 |
| 118 | Restrictive lung disease (HP:0002091) | 1.66284794 |
| 119 | Inappropriate behavior (HP:0000719) | 1.65662917 |
| 120 | Osteomyelitis (HP:0002754) | 1.65318703 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.64316795 |
| 122 | Hypoplasia of the odontoid process (HP:0003311) | 1.63277435 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.62738248 |
| 124 | Mucosal telangiectasiae (HP:0100579) | 1.61596787 |
| 125 | Cellulitis (HP:0100658) | 1.61441306 |
| 126 | Chronic diarrhea (HP:0002028) | 1.60658504 |
| 127 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60136533 |
| 128 | Bone cyst (HP:0012062) | 1.59825618 |
| 129 | Petechiae (HP:0000967) | 1.59275098 |
| 130 | Protuberant abdomen (HP:0001538) | 1.57491073 |
| 131 | Hemoptysis (HP:0002105) | 1.56577262 |
| 132 | Urinary incontinence (HP:0000020) | 1.56539096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 7.10352177 |
| 2 | NME2 | 4.66484203 |
| 3 | CSF1R | 3.40832362 |
| 4 | DDR2 | 3.29086449 |
| 5 | BLK | 3.12243748 |
| 6 | GRK7 | 3.03089792 |
| 7 | TYK2 | 2.80530326 |
| 8 | ERN1 | 2.76610195 |
| 9 | TBK1 | 2.63465787 |
| 10 | TAOK2 | 2.50629655 |
| 11 | ACVR1B | 2.37366406 |
| 12 | MAPK15 | 2.28939396 |
| 13 | RIPK4 | 2.19983785 |
| 14 | KIT | 2.13961334 |
| 15 | PIM2 | 2.06786475 |
| 16 | PAK4 | 2.03368753 |
| 17 | EPHB1 | 1.90796940 |
| 18 | ABL2 | 1.87342426 |
| 19 | NEK9 | 1.84790547 |
| 20 | PKN2 | 1.81071278 |
| 21 | JAK1 | 1.80059144 |
| 22 | CAMK1D | 1.79035733 |
| 23 | PDK2 | 1.76243780 |
| 24 | TAOK1 | 1.71175308 |
| 25 | SCYL2 | 1.69020648 |
| 26 | CAMKK2 | 1.67255317 |
| 27 | MAP3K14 | 1.61626463 |
| 28 | TRIB3 | 1.59723558 |
| 29 | TESK1 | 1.54063258 |
| 30 | IRAK4 | 1.52590156 |
| 31 | PRPF4B | 1.49255561 |
| 32 | IRAK3 | 1.48333917 |
| 33 | CDC42BPA | 1.48273727 |
| 34 | STK10 | 1.43620076 |
| 35 | MAP4K1 | 1.40474180 |
| 36 | MOS | 1.39137727 |
| 37 | MATK | 1.35156104 |
| 38 | TESK2 | 1.27586026 |
| 39 | ZAP70 | 1.23973613 |
| 40 | HCK | 1.20555795 |
| 41 | JAK2 | 1.20157212 |
| 42 | WNK4 | 1.18476938 |
| 43 | CAMKK1 | 1.16929360 |
| 44 | MAP2K3 | 1.16310033 |
| 45 | CAMK1G | 1.15608192 |
| 46 | IKBKB | 1.09451537 |
| 47 | CSK | 1.08814486 |
| 48 | OXSR1 | 1.07988153 |
| 49 | TSSK6 | 1.05468869 |
| 50 | MAP3K3 | 1.05397613 |
| 51 | FES | 1.04578390 |
| 52 | EPHB2 | 1.02683655 |
| 53 | FGR | 1.02204622 |
| 54 | TGFBR1 | 1.01191322 |
| 55 | PTK6 | 1.00715890 |
| 56 | BMPR2 | 0.97890579 |
| 57 | MAPK12 | 0.91924190 |
| 58 | LYN | 0.91820335 |
| 59 | MAP3K1 | 0.89852740 |
| 60 | IKBKE | 0.87913089 |
| 61 | CLK1 | 0.86076871 |
| 62 | LIMK1 | 0.85779101 |
| 63 | SYK | 0.84760240 |
| 64 | MAP2K6 | 0.81417011 |
| 65 | BMX | 0.78893267 |
| 66 | LCK | 0.77295226 |
| 67 | MAP3K5 | 0.75789280 |
| 68 | KDR | 0.75095251 |
| 69 | PDK1 | 0.73553271 |
| 70 | PDGFRA | 0.72603389 |
| 71 | DAPK2 | 0.70138921 |
| 72 | EGFR | 0.70085662 |
| 73 | TYRO3 | 0.68861423 |
| 74 | IRAK2 | 0.68720615 |
| 75 | PDPK1 | 0.68028422 |
| 76 | FGFR4 | 0.67290594 |
| 77 | GSK3A | 0.65668251 |
| 78 | TTN | 0.63739410 |
| 79 | RIPK1 | 0.63457888 |
| 80 | PTK2B | 0.63217790 |
| 81 | ITK | 0.61515461 |
| 82 | MAP3K13 | 0.61363968 |
| 83 | LRRK2 | 0.60342093 |
| 84 | PRKCD | 0.59310407 |
| 85 | WNK3 | 0.58491037 |
| 86 | IGF1R | 0.58236053 |
| 87 | IRAK1 | 0.57903022 |
| 88 | DAPK3 | 0.57766165 |
| 89 | SGK3 | 0.54855021 |
| 90 | TRPM7 | 0.53721689 |
| 91 | TXK | 0.52491732 |
| 92 | KSR2 | 0.52209836 |
| 93 | RET | 0.51818704 |
| 94 | GRK5 | 0.51701574 |
| 95 | BTK | 0.51672342 |
| 96 | MAPK7 | 0.51481056 |
| 97 | JAK3 | 0.49382636 |
| 98 | ICK | 0.48799879 |
| 99 | MARK3 | 0.47356478 |
| 100 | MAPK4 | 0.45860648 |
| 101 | PAK2 | 0.44946024 |
| 102 | MAPKAPK2 | 0.44149285 |
| 103 | PRKCH | 0.43294873 |
| 104 | MAP3K9 | 0.42961647 |
| 105 | PRKG2 | 0.42802005 |
| 106 | MAP3K11 | 0.42732226 |
| 107 | LATS2 | 0.42357867 |
| 108 | CAMK4 | 0.42209461 |
| 109 | INSR | 0.41665790 |
| 110 | LMTK2 | 0.39267393 |
| 111 | NTRK1 | 0.39163452 |
| 112 | ARAF | 0.39090111 |
| 113 | CHUK | 0.37849557 |
| 114 | WNK1 | 0.37848061 |
| 115 | RPS6KL1 | 0.37811979 |
| 116 | RPS6KC1 | 0.37811979 |
| 117 | SGK223 | 0.37775182 |
| 118 | SGK494 | 0.37775182 |
| 119 | ABL1 | 0.37029392 |
| 120 | PIM1 | 0.35459451 |
| 121 | SIK3 | 0.35127116 |
| 122 | MAP3K2 | 0.34085753 |
| 123 | PIK3CG | 0.32485576 |
| 124 | FYN | 0.32023337 |
| 125 | FGFR3 | 0.31444455 |
| 126 | PRKD1 | 0.31066398 |
| 127 | CDK6 | 0.31002271 |
| 128 | RPS6KA6 | 0.30793774 |
| 129 | BCKDK | 0.29458642 |
| 130 | SRC | 0.29309030 |
| 131 | PKN1 | 0.27892398 |
| 132 | ADRBK2 | 0.27529589 |
| 133 | MAP2K2 | 0.26829403 |
| 134 | DYRK3 | 0.26467884 |
| 135 | RPS6KA2 | 0.26256155 |
| 136 | MAPKAPK3 | 0.24357305 |
| 137 | SIK1 | 0.20943452 |
| 138 | MAP3K8 | 0.17959759 |
| 139 | CDK15 | 0.16909165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.96636484 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.58280470 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.37015909 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 4.13861189 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.92907378 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.47038768 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23206651 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14070542 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07359925 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.06158730 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 1.94473306 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84039077 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.79276458 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71846380 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.68697802 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61843733 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60322665 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59006796 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55822949 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48883973 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.47850941 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32260176 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.31245192 |
| 24 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17920459 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17140548 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16843467 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16810824 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.14038730 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05447183 |
| 30 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03081597 |
| 31 | Endocytosis_Homo sapiens_hsa04144 | 1.02333648 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01772616 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 0.93050021 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88022727 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 0.86917205 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85826848 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85381725 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84182773 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83663382 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 0.82850263 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82326164 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80577618 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80335587 |
| 44 | Measles_Homo sapiens_hsa05162 | 0.78752097 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78589290 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.78395345 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.78133844 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76558244 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.76429590 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73792061 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69595354 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69371173 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69344506 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68738198 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.68661304 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67732446 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66322987 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65558367 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63780291 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62709750 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.60501820 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58115414 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58039067 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57536446 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57448473 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55970446 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54965904 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54775024 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54533155 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54484809 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53777774 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52888990 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52636394 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52100666 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51149651 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48689251 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46686225 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46328869 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.46146100 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45637032 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44996200 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44936523 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44788630 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.43978201 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42478715 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.42137101 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42024036 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.41089494 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40673866 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40363134 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37558635 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37301838 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37162547 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35989532 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35756458 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35370787 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35311476 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35159309 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34871730 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.33846997 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32982453 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31256045 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30848143 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.30785621 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29350787 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27218363 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27114645 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26789547 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25860744 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25636257 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.24989442 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23223520 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20855701 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.20469060 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20298998 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19610946 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18827502 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17961872 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.17661899 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13564174 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12149904 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.10082641 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07031342 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.03897273 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.01921202 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.00163124 |

